Loading clinical trials...

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00509184

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma

Combination of involved field radiotherapy for the control of macroscopic disease and CD20 antibody Rituximab for the control of microscopic remainders in other regions in patients with early stage no...

Lead sponsor: Klaus Herfarth, MD•17 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 1

DS-3201b in Participants With Lymphomas

NCT02732275 · Lymphoma, Malignant, Non-hodgkin Lymphoma

COMPLETEDPhase 1

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

NCT02916979 · Leukemia, Lymphoid, Leukemia, Myeloid, and more

COMPLETEDPhase 1

A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

NCT01432951 · Solid Tumor, Lymphoma, Malignant

COMPLETEDPhase 2

Multi-day Doses in Prevention of Nausea and Emesis

NCT00600353 · Myeloma, Plasma-Cell, Lymphoma, Malignant

COMPLETEDPhase 1

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

NCT00078637 · Neoplasms, Lymphoma, Malignant

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 6, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment85

Start dateMar 2008

Last updatedJan 6, 2020

Condition

Lymphoma, Malignant

Locations shown

Charité Campus Mitte

Berlin

Charité Campus Benjamin-Franklin

Berlin

Charité Campus Buch

Berlin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 6, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

DS-3201b in Participants With Lymphomas

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

Multi-day Doses in Prevention of Nausea and Emesis

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

Trial snapshot

Condition

Locations shown

For caregivers